A, Huang S. Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation. Am J Physiol Renal Physiol 307: F396-F406, 2014. First published February 26, 2014 doi:10.1152/ajprenal.00565.2013.-Hyperuricemia is associated with kidney complications including glomerulosclerosis and mesangial cell (MC) proliferation by poorly understood mechanisms. The present study investigated the underlying mechanisms that mediate uric acid (UA)-induced MC proliferation. A rat MC line, HBZY-1, was treated with various concentrations of UA in the presence or absence of a specific extracellular-regulated protein kinase 1/2 (ERK1/2) inhibitor (U0126), apocynin. UA dose dependently stimulated MC proliferation as shown by increased DNA synthesis and number of cells in the S and G 2 phases in parallel with the upregulation of cyclin A2 and cyclin D1. In addition, UA time dependently promoted MC proliferation and significantly increased phosphorylation of ERK1/2 but not c-Jun NH 2-terminal kinase and p38 MAPK in MCs as assessed by immunoblotting. Inhibition of ERK1/2 signaling via U0126 markedly blocked UA-induced MC proliferation. More importantly, UA induced intracellular reactive oxygen species (ROS) production of MCs dose dependently, which was completely blocked by apocynin, a specific NADPH oxidase inhibitor. Toll-like receptor (TLR)2 and TLR4 signaling had no effect on NADPH-derived ROS and UA-induced MC proliferation. Interestingly, pretreatment with apocynin inhibited ERK1/2 activation, the upregulation of cyclin A2 and cyclin D1, and MC proliferation. In conclusion, UA-induced MC proliferation was mediated by NADPH/ROS/ERK1/2 signaling pathway. This novel finding not only reveals the mechanism of UAinduced MC cell proliferation but also provides some potential targets for future treatment of UA-related glomerular injury.
URIC ACID (UA) IS AN INTERMEDIARY product of the purine degradation pathway in cells. It is generated by xanthine oxidase (XO) oxidizing hypoxanthine and xanthine. Most mammals have low serum UA levels because of the presence of uricase, a hepatic enzyme that degrades UA to allantoin. Humans and great apes lack this enzyme because of several mutations that occurred during early hominoid evolution 10 -15 million years ago (36) . Therefore, humans are prone to hyperuricemia. Any events that increase UA formation and/or inhibit elimination can result in hyperuricemia. Recently, it was determined that hyperuricemia is not only important in the biochemical mechanism of gout but is also closely related to hypertension, hyperlipidemia, atherosclerosis, obesity, and insulin resistance and is now a part of metabolic syndrome and a risk factor for cardiovascular diseases (12, 26) . Additionally, hyperuricemia is closely related to renal diseases (14) . Furthermore, elevated UA increases the risk of chronic kidney disease (2, 25, 35) . To date, studies of UA in the kidney have mainly concentrated on intrarenal deposition of UA crystals that could stimulate renal interstitial fibrosis (29, 33) . However, the direct effect of circulating UA on mesangial cells (MCs) remains unclear.
When exposed to an injurious stimulus, MCs undergo cellular proliferation and matrix synthesis, leading to an increase in MC numbers and matrix accumulation. MCs are controlled by many factors, such as cytokines, growth mediators, matrix components, and interactions with other cells. Therefore, MCs have an important role in glomerular diseases (27, 31) . In this study, we examined the proliferative effects of UA on rat glomerular MCs and further explored its possible mechanisms in vitro.
MATERIALS AND METHODS
Reagents and antibodies. DMEM medium was purchased from GIBCO (Carlsbad, CA). UA, apocynin, PD98059, and 2=,7=-dichlorofluorescein diacetate (DCFDA) were purchased from Sigma Chemical (St. Louis, MO). Cyclin D1 mouse monoclonal antibody and cyclin A2 rabbit polyclonal antibody were purchased from Abcam. Rabbit antibodies against ␤-actin, phospho-ERK1/2, total ERK1/2, phospho-JNK, phospho-p38, TLR2, and TLR4 were obtained from Cell Signaling Technology (Danvers, MA). U0126 was purchased from Merck (Haar, Germany). Peroxidase-conjugated AffiniPure goat anti-rabbit and goat anti-mouse secondary antibodies were from Zhongshan Gold Bridge Biotechnology (Beijing, China).
MC culture and siRNA transfection. The rat MC line HBZY-1 was obtained from the China Center for Type Culture Collection (CCTCC, Wuhan, China). Cells were cultured in DMEM containing 5.6 mM glucose, 10% fetal bovine serum (FBS; GIBCO), 100 U/ml penicillin, 100 mg/ml streptomycin, 44 mM NaHCO 3, and 14 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid at 37°C at 5% CO 2 and passaged every 2 or 3 days. After digestion with 0.25% trypsin and 0.02% EDTA, cells at a density of 3 ϫ 10 4 /ml were seeded in 96-well plates for [ 3 H]thymidine incorporation and in 24-well plates for cell counting. siRNAs for TLR2 and TLR4 were purchased from Gene Pharma (Shanghai, China). TLR2 siRNA consisted of an RNA duplex containing a sense strand: 5=-GGCUCUUUGACGAGAACAATT-3= and an antisense strand: 5=-UUGUUCUCGUCAAAGAGCCTT-3=. TLR4 siRNA consisted of an RNA duplex containing a sense strand: 5=-GGCUGGCAAUUCUUUCAAATT-3= and an antisense strand: 5=-UUUGAAAGAAUUGCCAGCCTT-3=. Cells were transfected with siRNAs 24 h before experiments were initiated according to the siRNA instructions. Six-well plates were used in all other experiments.
DNA synthesis and cell counting. Proliferation was assessed by [ 3 H]thymidine incorporation and cell counting. To measure the syn-thesis of DNA, pellets were resuspended into DMEM with 1% FBS and then placed in 96-well plates. Cells were incubated with [
3 H]thymidine (5 Ci/ml). Following the indicated treatment, cells were harvested by incubation at 4°C with trichloroacetic acid (5%) followed by solubilization in 0.1 N NaOH. Radioactivity was determined by scintillation counting. To assess cell growth, MCs in 24-well plates were stimulated by the indicated agents, and the cell number was counted with a Z1-Coulter Counter (Luton, UK).
Cell cycle analysis. MCs stimulated with the indicated agents were incubated in DMEM with 0.5% FBS for 24 h. Samples were then washed twice with PBS and resuspended in 70% ethanol for 2 h at 4°C. Fixed and permeated cells were collected by centrifugation, treated with RNase, and stained with propidium iodide. The number of cells in G 1, S, and G2/M cell cycle phases was analyzed by flow cytometry using a FACSCalibur Flow Cytometer (Becton Dickinson, San Jose, CA).
Real-time PCR. Total RNA was isolated using a TRIzol Total RNA Isolation Kit (Invitrogen) according to the manufacturer's protocol. Reverse transcription was performed using a Superscript III RT Kit (Invitrogen) according to the manufacturer's protocol. Briefly, the reactions were incubated at 65°C for 5 min and then at 50°C for 60 min. Oligonucleotides (cyclin D1: forward, 5=-CGC CCT CCG TTT CTT ACT TC-3= and reverse, 5=-GCA GTC AGG GGA ATG GTC T-3=; cyclin A2: forward, 5=-AAG ATG CCC TGG CTT TTA GTG-3= and reverse, 5=-TAA CAT TCA CTG GCT TTT CGT CT-3=; TLR2: forward, 5=-GTC CAT GTC CTG GTT GAC TGG-3= and reverse, 5=-GAT ACC ACA GCC CAT GGA AAT-3=; TLR4: forward, 5=-GCC GGA AAG TTA TTG TGG TGGT-3= and reverse, 5=-ATG GGT TTT AGG CGC AGA GTT T-3=; and GAPDH: forward, 5=-CAA GTT CAA CGG CAC AGT CAA-3= and reverse, 5=-TGG TGA AGA CGC CAG TAG ACT C-3=) were designed using Primer3 software (available at http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and synthesized by Invitrogen. Real-time PCR amplification was performed using SYBR Green Master Mix (Applied Biosystems, Foster City, CA) and the ABI Prism 7500 Real-Time PCR System (Applied Biosystems). Cycling conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Relative amounts of mRNA were normalized to GAPDH and calculated using the delta-delta method from the threshold cycle numbers.
Western blot analysis. At the indicated time points, MCs were rapidly washed with ice-cold PBS and lysed for 10 min on ice in lysis buffer containing 1% Triton X-100, 250 M phenylmethanesulfonyl fluoride, 2 mM EDTA, and 5 mM dithiothreitol (pH 7.5). After centrifugation, the protein level was determined in supernatants using a Micro BCA protein assay kit with bovine serum albumin as a standard (Pierce, Thermo). In brief, 30 g protein were used for electrophoresis on SDS-PAGE and transferred to a nitrocellulose fibrous membrane. The blots were blocked in 5% nonfat dry milk for 1 h, followed by overnight incubation at 4°C with antibodies against cyclin D1, cyclin A2, ␤-actin, phospho-p38, phospho-JNK, phospho-ERK1/2, or total ERK1/2 at a dilution of 1:1,000. After being washed with TBS, blots were incubated with a horseradish peroxidase-conjugated secondary antibody at room temperature for 1 h and then visualized with an enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Piscataway, NJ).
DCFDA fluorescence measurement of ROS. The fluorogenic substrate DCFDA is a cell-permeable dye that is oxidized to highly fluorescent 2=,7=-dichlorofluorescein (DCF) by H 2O2 and is used to monitor intracellular ROS generation (18) . To quantitate ROS levels, MCs were seeded in six-well plates. At confluence, cells were washed twice with PBS, incubated for 30 min with 10 M DCFDA, and then treated as indicated. After incubation, cells were washed twice with PBS and imaged by fluorescence microscopy. To quantitate ROS levels, relative fluorescence was analyzed by flow cytometry.
Statistical analysis. All values were expressed as the means Ϯ SE. Statistical analysis was performed by one-way ANOVA and Bonfer- Fig. 3 . Effects of UA on expressions of cyclin D1 and cyclin A2 in rat MCs. After MCs were treated with UA (300 M), a time-dependent increase of cyclin D1 (A) and cyclin A2 (B) mRNA levels was observed. Meanwhile, a dose-dependent induction of cyclin D1 and cyclin A2 mRNA expressions following 12 h UA treatment (C) and protein levels following 24 h UA administration (D and E) was also determined. Values are means Ϯ SD; n ϭ 5. *P Ͻ 0.05 vs. control. roni tests. A P value of Ͻ0.05 was considered statistically significant. Five samples were used in the experiments.
RESULTS
UA induces MC proliferation. The effects of UA on MC proliferation were examined by measuring [ 3 H]thymidine uptake and counting cell numbers. After MCs were cultivated to 60 -70% confluence, they were treated with various concentrations of UA (50, 100, and 300 M) for 24 h. Cell counting showed that the number of cells in the UA-stimulated groups (50, 100, and 300 M) increased ϳ1.25-, 1.53-, and 1.59-fold, respectively, compared with the control group (Fig. 1A) . Moreover, the amount of [ 3 H]thymidine incorporation in the UAstimulated groups (50, 100, and 300 M) was increased ϳ1.08-, 1.24-, and 1.56-fold compared with the control group (Fig. 1B) . These data indicate that UA induced MC proliferation in a dose-dependent manner.
MCs were exposed to UA for 5 days. From the first day, the amount of [ 3 H]thymidine incorporation and the cell number in the UA-stimulated group were significantly increased compared with the control group (Fig. 1, C and D) . These results suggest longer term exposure to UA also promotes MC proliferation.
UA induces cell cycle progression in MCs. UA decreased MC numbers in the G 1 /G 0 phase and increased cell numbers in the S phase in a dose-dependent manner, suggesting UA stimulates cell cycle progression in rat MCs (Fig. 2) .
UA increases the expression of cyclin D1 and cyclin A2 in MCs. PCR and Western blot analysis of G 1 /S-phase cyclins showed that UA significantly increased the expression levels of cyclin D1 and cyclin A2 in a time-and dose-dependent manner (Fig. 3) . These results indicate that the expression levels of cyclin D1 and cyclin A2 were significantly increased at both the transcriptional and translational levels.
UA stimulates ERK1/2 but not p38 and JNK signaling in MCs. To study the intracellular pathways involved in UAinduced MC proliferation, we examined the effect of UA on MAPK signaling. Cultured rat MCs were treated with various concentrations of UA (50, 100, or 300 M) for 1 h. We found that UA increased ERK phosphorylation in MCs (Fig. 4, A and B) . However, no differences were observed in phospho-JNK and phospho-p38 expression between UA-stimulated MCs and the control group (Fig. 4, C and D) . We observed that ERK phosphorylation induced by UA in MCs was reduced from the second hour (Fig. 4, E and F) .
Moreover, U0126, a specific inhibitor of ERK1/2, significantly decreased the level of ERK1/2 phosphorylation compared with the UA-stimulated group (300 M; Fig. 5, A and B) . PCR analysis demonstrated that U0126 also reduced the expression levels of cyclin D1 and cyclin A2 (Fig. 5, C and D) . In cells pretreated with U0126 for 30 min followed by UA (300 M) treatment for 24 h, cell counting and [
3 H]thymidine incorporation demonstrated an inhibition rate of 22 and 31%, respectively (Fig. 5, E and F) . We used PD98059, another inhibitor of ERK1/2, to confirm the role of ERK1/2 in UAinduced MC proliferation. The results were similar to U0126 (Fig. 6 ). These findings suggest that activation of ERK1/2 is a necessary step for MC proliferation induced by UA.
Involvement of NADPH oxidase-derived ROS generation in UA-induced MC proliferation.
The mechanism of UA activation of the ERK pathway remains to be elucidated. In adipocytes, the redox-dependent effects of UA are mediated by the activation of intracellular oxidant production via NADPH oxidase (30) . Oxidative stress has extensive and profound effects in renal diseases. Therefore, we explored the association between UA and oxidative stress on MCs. Using DCFDA, we demonstrated that ROS production upon UA stimulation exhibited a concentration-dependent response (Fig. 7, A and B) . Figure   7B shows that UA increased ROS production in a concentrationdependent manner with a maximal stimulation at 300 M. Furthermore, apocynin completely inhibited UA-stimulated ROS production (Fig. 7C) . These findings suggest UA could increase ROS production via the NADPH oxidase pathway.
The role of TLR2 and TLR4 on UA-induced ROS and MC proliferation. TLR2 and TLR4 function as pattern recognition receptors that augment the expression of NADPH oxidase in some conditions (16, 19 -21) . It is unknown whether TLR2 and TLR4 signaling contributes to NADPH oxidase-derived ROS and MC proliferation induced by UA. UA had no effect on the expression of TLR2 and TLR4 on MCs (Fig. 8, A and B) . TLR2 and TLR4 expression was inhibited by TLR2 and TLR4 siRNAs (Fig. 8, C-F) . Figure 8 , G and H, shows that NADPH oxidase-derived ROS generated from UA-treated MCs was not reduced by UA-treated MCs transfected with siTLR2 or siTLR4. There was no change in proliferation of UA-treated MCs transfected with siTLR2 or siTLR4 compared with the UA group ( Fig. 9 and 10) . The results suggest TLRs had no effect on UA-induced ROS and MC proliferation.
Role of ROS in UA-induced MC proliferation via ERK1/2 signaling.
Previous studies demonstrated that ROS induction activates the ERK pathway (4, 5, 17) . Western blot analysis showed that apocynin significantly inhibited UA-induced ERK1/2 phosphorylation simultaneously (Fig. 11A) . Apocynin suppressed the expression of cyclin D1 and cyclin A2 (Fig. 11, B and C) . ]thymidine incorporation and cell counting showed that apocynin inhibited UA-induced cell proliferation (Fig. 11, D and E) . Thus UA stimulates rat MC proliferation partially by increasing the expression of cyclins by activation of the ERK pathway via NADPH oxidase-derived ROS generation.
DISCUSSION
In this study, we reported that UA stimulated rat MC proliferation in a dose-dependent manner in vitro, partially by increasing the expression of cyclins by activation of the ERK pathway via NADPH oxidase-derived generation.
ROS can contribute to the process of renal diseases and might act as second messengers that regulate various intracellular signal transduction cascades and the activity of various transcription factors, leading to inflammation, apoptosis, fibrosis, and cell proliferation (6) . Although UA is often thought of as an antioxidant, several studies have demonstrated that UA can be pro-oxidative and generate free radicals (10, 12, 15) . Therefore, this study explored the association between UA and oxidative stress on rat glomerular MCs in vitro.
Recent studies demonstrated that ERK1/2 participates in MC proliferation in vitro and regulates renal activity in experimental glomerulonephritis (13, 34) . These studies proposed that ERK is of vital importance in cell cycle regulation. MAPKs, a family of Ser/Thr protein kinases, are the major signal transduction molecules responsible for cellular responses and include three primary members: ERK1/2, c-Jun NH 2 -terminal kinase (JNK), and p38. ERK1/2 signaling mainly mediates cell proliferation (3) . A previous report indicated that different concentrations of U0126 had a different efficiency on inhibition of ERK1/2 signaling and that the efficiency of U0126 was higher than for PD98059 (1, 3, 9) . Because the concentration of U0126 used in the current study efficiently inhibited ERK1/2 signaling, pERK levels were reduced to below baseline control Fig. 6 . Effect of ERK1/2-specific inhibitor PD98059 on UA-induced MC proliferation. A and B: Cells were pretreated with PD98059 (10 M) for 30 min and then 1-h treatment of UA at a dose of 300 M was performed. Whole cell protein extract was prepared for Western blotting using antibodies against P-ERK1/2 or total-ERK (A and B) . For the mRNA analysis of cyclin D1 (C) and cyclin A2 (F), cells were pretreated with PD98059 for 30 min followed by 12 h UA (300 M) treatment. For the protein analysis of cyclin D1 (D and E) and cyclin A2 (G and H) and cell proliferation determined by cell counting (I) and [ 3 H]thymidine incorporation (J), MCs were pretreated with PD98059 for 30 min followed by 24 h UA (300 M) treatment. Values are means Ϯ SD; n ϭ 5. *P Ͻ 0.05 vs. the control; #P Ͻ 0.05 vs. the UA group. levels with the inhibitor U0126 but not PD98059. Apocynin reduced pERK levels to below baseline control levels in the experiments. The mechanism of this phenomenon was not clear.
Although increasing evidence suggests that proliferation of various cell types is dependent on ROS generated by oxidantgenerating systems after growth factor stimulation (24) , the source of UA-induced ROS remains unclear. It was reported that many enzymes participate in ROS production in vivo, such as those in the mitochondria pathway, NADPH oxidase, xanthine oxidase, cyclooxygenase, lipoxygenase, cytochrome P450 oxidase, and nitric oxide synthase (7) . We report that NADPH oxidase inhibitor apocynin significantly inhibited UA-induced ROS production, ERK phosphorylation, and cell proliferation.
Early in 2005, Liu-Bryan et al. (22) demonstrated that UA binds and signals through TLR2 and TLR4. Other reports have Fig. 7 . Effect of UA on reactive oxygen species (ROS) production. ROS production was detected by the dye 2=,7=-dichlorofluorescein diacetate (DCFDA), and 2=,7=-dichlorofluorescein (DCF) fluorescence was quantified by flow cytometry as described in MATERIALS AND METHODS. A and B: rat MCs were treated with the indicated doses of UA (0, 50, 100, or 300 M) for 1 h. The fluorescence was imaged by fluorescence microscopy (A), and the DCF florescence was quantified using flow cytometry (B). C: rat MCs were pretreated with apocynin (500 M) for 30 min followed by UA (300 M) treatment for 1 h. The fluorescence was quantified using flow cytometry. Values are means Ϯ SD; n ϭ 5. *P Ͻ 0.05 vs. control; #P Ͻ 0.05 vs. UA group. shown that TLR2 or TLR4 are related to NADPH-derived ROS (16, 19 -21) , but in the current study TLR2 or TLR4 signaling had no effect on ROS induced by UA or on UA-induced MC proliferation. The results imply TLR2 and TLR4 do not participate in the process of UA-stimulated MC proliferation. Furthermore, UA induced the activation of dendritic cells that lacked TLR4 expression (32) . In addition, UA was found to require NLRP3, another innate immune receptor, for the production of IL-1␤ by macrophages (23) . These findings might partially explain why TLRs have no effect on UA-triggered MC proliferation. Further study is required to determine the role of NLRP3 inflammasome in UA-induced MC proliferation.
In this study, we observed that UA significantly increased the expression of cyclin D1 and cyclin A2 in a dose-dependent manner but also found that UA could induce apoptosis of MCs (data not shown). These findings indicate that UA induces MC apoptosis during proliferation. It is important to determine whether proliferation or apoptosis has a more important role when MCs are stimulated by UA. MC apoptosis has been proposed as a means of resolution of glomerular hypercellularity in proliferative forms of glomerular disease (8) . Perhaps increased apoptosis is a mechanism of protecting MCs. However, the mechanism of UA-induced MC apoptosis and the relationship between MC proliferation and apoptosis are unclear and require further study.
Cell proliferation is ultimately regulated at the level of cell cycle progression through the four stages of G 1 , S, G 2 , and M with important checkpoints in G 1 and G 2 . Cyclin D1 controls cell cycle progression through the G 1 phase and G 1 -to-S transition (28) , and cyclin A-associated kinase activity is required for entry into S, completion of S, and entry into M phase (11) . The experiment designed in this study examined the expressions of cyclin D1 and cyclin A2 as markers of cell cycle progression. We did not examine the expression levels of p53, p27, or p21, cyclin-dependent kinase inhibitors. Cyclin kinase inhibitors inhibit cell proliferation by binding to and inactivating specific cyclin-CDK complexes. Future studies should determine the expression levels of p53, p27, and p21. The mechanisms of UA-induced renal disease are known and include endothelial dysfunction, epithelial-mesenchymal transition, local inflammatory reactions in the kidney, and altered glomerular hemodynamics. UA-induced MC proliferation may be another mechanism that explains renal diseases secondary to hyperuricemia. 
